Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.

Literature | 7,122 results

View All

• Hyperparathyroidism.

  Authors: William D Fraser

  Lancet 2009 Jul 11

• Engineering parathyroid cells to treat secondary hyperparathyroidism.

  Authors: Mariano Rodríguez, Julio M Martinez-Moreno, Yolanda Almadén

  Kidney international 2009 Mar

Associated Researchers

Thought leaders and organizations working on research involving secondary hyperparathyroidism.

View All Authors

• Fong-Fu Chou
• Chien-Te Lee
• Quan-Yang Duh
• Mariano Rodríguez
• Jin-Bor Chen

View All Clinical Trials Sponsors

• Amgen
• Abbott
• Genzyme
• Papageorgiou General Hospital
• Cytochroma Inc.

View All Organizations

• University of Milan
• Chang Gung University College of Medicine
• University of Liverpool
• Hospital Universitario Reina Sofía
• Hadassah Hebrew University Medical Center

Clinical Trials | 191 trials

View All

• Acute Regulation of Parathyroid Hormone by Dietary Phosphate

  conditions: Secondary Hyperparathyroidism

  interventions: none

   

• ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

  conditions: Secondary Hyperparathyroidism

  interventions: Sensipar®

   

News | 1 story

View All

• [Seminar] Hyperparathyroidism

  Lancet. - July 09, 2009

Community

View All NextBio Users | 2 people

• Fatima  Silva-Netto

• Joan  Fibla

  Dr

  University of Lleida

NextBio Groups

• No NextBio groups were found for “secondary hyperparathyroidism”.
  Be the first to start a group and share your interests with others within the NextBio community.

search → result

search → result